Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.2% |
| 2 | Healthcare | 7.6% |
| 3 | Financials | 5.15% |
| 4 | Consumer Discretionary | 5.03% |
| 5 | Industrials | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Primerica
PRI
$9.98B
| $3.89M | ﹤0.01% |
20,075
+9,678
| +93% | +$1.98M |
|
2877
PUT
Invesco Solar ETF
TAN
$1.42B
| $3.89M | ﹤0.01% |
75,200
+23,600
| +46% | +$1.45M |
|
2878
Ormat Technologies
ORA
$6B
| $3.89M | ﹤0.01% |
55,686
+32,780
| +143% | +$2.54M |
|
2879
Pulmonx
LUNG
$68.8M
| $3.89M | ﹤0.01% |
376,633
-202,438
| -35% | -$2.34M |
|
2880
Aldeyra Therapeutics
ALDX
$92.9M
| $3.89M | ﹤0.01% |
582,178
+86,603
| +17% | +$643K |
|
2881
Ultragenyx Pharmaceutical
RARE
$2.45B
| $3.88M | ﹤0.01% |
108,948
+53,503
| +96% | +$2.12M |
|
|
PDM
2882
Piedmont Realty Trust
PDM
$1.21B
| $3.88M | ﹤0.01% |
691,015
+212,559
| +44% | +$1.46M |
|
2883
CALL
Jazz Pharmaceuticals
JAZZ
$15.9B
| $3.88M | ﹤0.01% |
+30,000
| New | +$4M |
|
2884
Neumora Therapeutics
NMRA
$298M
| $3.88M | ﹤0.01% |
+274,748
| New | +$3.43M |
|
2885
iRadimed
IRMD
$1.16B
| $3.87M | ﹤0.01% |
87,179
+31,876
| +58% | +$1.48M |
|
|
NWLI
2886
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $3.87M | ﹤0.01% |
+8,835
| New | +$3.88M |
|
2887
UroGen Pharma
URGN
$1.86B
| $3.86M | ﹤0.01% |
275,785
+83,657
| +44% | +$1.34M |
|
2888
The RMR Group
RMR
$325M
| $3.86M | ﹤0.01% |
157,248
-32,909
| -17% | -$793K |
|
2889
CALL
Guardant Health
GH
$21.7B
| $3.85M | ﹤0.01% |
+130,000
| New | +$4.57M |
|
2890
Costamare
CMRE
$1.88B
| $3.85M | ﹤0.01% |
400,387
+354,968
| +782% | +$3.62M |
|
|
SGI
2891
Somnigroup International
SGI
$13.7B
| $3.85M | ﹤0.01% |
88,822
-502,933
| -85% | -$22.3M |
|
|
PPBI
2892
DELISTED
Pacific Premier Bancorp
PPBI
| $3.85M | ﹤0.01% |
176,859
-244,856
| -58% | -$5.64M |
|
2893
Scorpio Tankers
STNG
$3.9B
| $3.84M | ﹤0.01% |
71,017
-167,475
| -70% | -$8.18M |
|
2894
XBiotech
XBIT
$68M
| $3.84M | ﹤0.01% |
931,444
-28,314
| -3% | -$142K |
|
|
DADA
2895
DELISTED
Dada Nexus
DADA
| $3.84M | ﹤0.01% |
861,978
+753,768
| +697% | +$4.01M |
|
2896
Stewart Information Services
STC
$2.06B
| $3.83M | ﹤0.01% |
87,453
+79,493
| +999% | +$3.6M |
|
|
INFN
2897
DELISTED
Infinera Corporation Common Stock
INFN
| $3.83M | ﹤0.01% |
915,183
+503,325
| +122% | +$2.17M |
|
|
NOA
2898
North American Construction
NOA
$369M
| $3.82M | ﹤0.01% |
175,847
+136,373
| +345% | +$3.08M |
|
2899
Oxford Industries
OXM
$566M
| $3.81M | ﹤0.01% |
39,680
-145,085
| -79% | -$14.7M |
|
2900
PUT
Hercules Capital
HTGC
$3.07B
| $3.81M | ﹤0.01% |
231,900
+127,400
| +122% | +$2.09M |
|
Similar funds
Millennium Management's Q3 2023 Portfolio in Review
As of Q3 2023, Millennium Management held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Millennium Management's Q3 2023 filing shows 836 new, 2,327 increased, 2,312 reduced and 834 closed positions. Its largest new stake was Mobileye: 2,953,164 shares worth $123M. The largest sale was iShares Core S&P 500 ETF, an estimated $689M.
By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Financials.
- Millennium Management's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Millennium Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Millennium Management fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Millennium Management's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Millennium Management opened 836 new positions and closed 834 in Q3 2023.
- Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.